Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 1/20 | 0.57 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | RAF1 | P04049 | 1/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24556963 | 1.00 | CYP11B2 (0.57) | CYP11B2S1PR1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL24556967 | 1.00 | CYP11B2 (0.57) | CYP11B2S1PR1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL29173244 | 1.00 | CYP11B2 (0.57) | CYP11B2S1PR1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL24602720 | 1.00 | CYP11B2 (0.57) | CYP11B2S1PR1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL6419399 | 0.97 | CYP11B2 (0.54) | CYP11B2S1PR1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL1515154 | 0.92 | CYP11B2 (0.48) | CYP11B2S1PR1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL1515255 | 0.87 | — | — | |
| SCHEMBL31621355 | 0.87 | S1PR1 (0.64) | CYP11B2S1PR1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL18899602 | 0.84 | S1PR1 (0.47) | CYP11B2S1PR1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL23918348 | 0.82 | S1PR1 (0.48) | CYP11B2S1PR1CYP2C19CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2006503104-A | — | — | 2006-01-26 | — | — | JP | claimed |
| EP-1513612-A2 | GAS STORAGE MATERIALS AND DEVICES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2005-03-16 | — | — | EP | claimed |
| WO-2004042270-A2 | GAS STORAGE MATERIALS AND DEVICES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2004-05-21 | — | — | WO | claimed |
| EP-4318630-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY | ASAHI CHEMICAL IND (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-12199280-B2 | Non-aqueous secondary battery and non-aqueous electrolyte | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-01-14 | — | — | US | disclosed |
| EP-4415105-A2 | NON-AQUEOUS SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-08-14 | — | — | EP | disclosed |
| US-20240178452-A1 | Nonaqueous Electrolyte Solution and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-05-30 | — | — | US | disclosed |
| CN-117702142-A | C (C) 4 Process for preparing substituted pyridine derivatives | 五邑大学 | 2024-03-15 | — | — | CN | disclosed |
| EP-4318630-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY | Asahi Kasei Kabushiki Kaisha (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117223143-A | Nonaqueous electrolyte and nonaqueous secondary battery | 旭化成株式会社 | 2023-12-12 | — | — | CN | disclosed |
| CN-116262749-A | Aromatic heterocycle substituted compound and preparation method and application thereof | 上海翊石医药科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| WO-2001056358-A2 | ENHANCED PROPERTIED PESTICIDES | ROHM AND HAAS COMPANY (US) | 2001-08-09 | — | — | WO | disclosed |
| US-4495353-A | ETHERIFICATION OF A HALOAROMTIC COMPOUND | STERLING DRUG INC. (US) | 1985-01-22 | — | — | US | disclosed |
| EP-0057321-B1 | PROCESSES FOR SUBSTITUTION OF AROMATIC ORGANIC COMPOUNDS | STERWIN AG. (CH) | 1984-03-21 | — | — | EP | disclosed |
| US-4422955-A | REPLACING HALOGEN ATOM ATTACHED TO RING WITH ALKOXY-TYPE SUBSTITUENT USING AS CATALYST A FORMIC ACID ESTER AND A CUPROUS SALT | STERLING DRUG INC. (US) | 1983-12-27 | — | — | US | disclosed |
| EP-0057321-A1 | Processes for substitution of aromatic organic compounds | STERWIN AG. (CH) | 1982-08-11 | — | — | EP | disclosed |
| US-4286085-A | PROMOTERS INTERFACIAL POLYMERIZATION | GENERAL ELECTRIC COMPANY (US) | 1981-08-25 | — | — | US | disclosed |
| US-4041057-A | Hydroesterification process | ETHYL CORPORATION (US) | 1977-08-09 | — | — | US | disclosed |
| US-3976670-A | CARBON MONOXIDE, ALCOHOL, METAL CARBONYL CATALYST | ETHYL CORPORATION (US) | 1976-08-24 | — | — | US | disclosed |
| US-3935228-A | HYDROESTERIFICATION CATALYST | ETHYL CORPORATION (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12199280-B2 | Non-aqueous secondary battery and non-aqueous electrolyte | CLK2, TYK2, CLK3 | CYP11B2 3146/4885S1PR1 4501/4885CYP2C19 2909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.